Work

Abstract 1601: Advancing cancer immunotherapy: Unveiling the potential of PD-L1-targeted IFN-α2a dutaflip molecule through patient-derived tumor explants

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-1601

Authors: Steffen Dettling, Martina Antoniolli, Kerstin Pätzold, Manuela Gies, Jakob Rosenhauer, Jens Liedke, Laura Krümpelmann, Marion Lichtenauer, David Lamparter, Tai-Hsien Ou Yang, Petra Schwalie, Gabriel Schnetzler, Andreas Roller, Moritz Rapp, Meher Majety, Pablo Umaña, Marina Bacac

Institution: Roche (Switzerland)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409627614

Cites:

Cited by: 1

Related to: 10